A randomized, open-label, active-controlled, phase 1b study of pharmacokinetics, tolerance and efficacy of GLS4 combination with ritonavir for treating chronic HBV infection
Latest Information Update: 20 Jul 2020
At a glance
- Drugs Morphothiadine (Primary) ; Entecavir; Ritonavir
- Indications Hepatitis B
- Focus Pharmacokinetics
- 20 Jul 2020 New trial record
- 10 Jul 2020 Results published in the Clinical Infectious Diseases